Core Screen
Deep Compare Cockpit
Evaluate architecture-level trade-offs, uncertainty, and failure risk. The goal is decision quality—not leaderboard ranking.
Comparison dimensions
Target-organ efficiency
Cell specificity
Payload compatibility
Durability fit
Liver detargeting
Barrier penetration
Immune escape
Innate activation risk
Repeat-dose plausibility
Manufacturability
Translational evidence
Operational simplicity
Cost viability
Post-entry confidence
Radar trade-off map
Recommendation / uncertainty / failure risk
Sticky recommendation
Engineered AAV systemic CNS delivery
Best aggregate strategic fit despite elevated immunity and translation uncertainty.
Trade-off tags
High efficacy upside
Liver detargeting essential
Immune risk managed, not solved
Confidence indicators
Engineered AAV systemic CNS
Confidence window: 66%
Failure risk: 38%
High efficacy upside
Immunity watch
BBB strategic fit
Intrathecal/local AAV
Confidence window: 73%
Failure risk: 31%
Strong feasibility
Procedure burden
Regional coverage limit
LNP transient editor
Confidence window: 51%
Failure risk: 52%
Redose optionality
Durability gap
CNS exposure risk